Summary of
Effect of β-Hydroxybutyrate Monoester on Markers of Iron Metabolism in New-Onset Prediabetes: Findings from a Randomised Placebo-Controlled Trial
By
Purpose
To determine whether BHB monoester supplementation affects markers of iron metabolism and oxidative stress in individuals with new-onset prediabetes.
Methods
In this double-blind, placebo-controlled trial, 18 prediabetic adults were randomized to receive either 25g of BHB monoester or placebo daily for 4 weeks. Blood samples were analyzed for iron metabolism markers (ferritin, hepcidin) and antioxidant status.
Results
The BHB group showed a significant reduction in serum ferritin (a marker of iron stores and inflammation) and an increase in total antioxidant capacity. No significant changes were observed in serum hepcidin or C-reactive protein. These results suggest that BHB may modulate iron regulation independently of traditional inflammatory markers.
Conclusion
Daily BHB monoester intake can improve iron-related biomarkers and enhance antioxidant defenses in individuals with prediabetes, supporting its role in metabolic health and inflammation reduction.